Cancelled by the investigator.Study of the lowest effective dose of ropivacaine for ultrasound-guided iliofascial space block in inguinal ligaments

Study of the lowest effective dose of ropivacaine for ultrasound-guided iliofascial space block in inguinal ligaments

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400092957

Enrollment

Unknown

Registered

2024-11-26

Start date

2024-12-01

Completion date

Unknown

Last updated

2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patella fracture

Interventions

Case series:Sequential method

Eligibility

Sex/Gender

All

Age

30 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients who were eligible for femur and knee surgery were of all genders, aged 30 to 80 years, BMI 18 to 28 kg /m2, and ASA grade I to III.

Exclusion criteria

Exclusion criteria: 1) Have a history of mental and nervous system diseases or combined with craniocerebral injury can not communicate normally; 2) Abnormal coagulation function; 3) Peripheral neuromuscular disease; 4) The puncture site has a history of infection; 5) Known ropivacaine allergy; 6) Refuse to participate in this experimental study.

Design outcomes

Primary

Measure	Time frame
Ropivacaine 90% minimum effective concentration;Half of the effective capacity;	—

Secondary

Measure	Time frame
rate of success;Complications;	—

Countries

China

Contacts

Public ContactChenHang

Chongqing Orthopedic Hospital of Traditional Chinese Medicine

chenhangcynthia@foxmail.com+86 185 2344 3212

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026